We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Understanding Dentsply (XRAY) Reliance on International Revenue
Read MoreHide Full Article
Have you evaluated the performance of Dentsply International's (XRAY - Free Report) international operations for the quarter ending March 2024? Given the extensive global presence of this dental products manufacturer, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth.
In the modern, closely-knit global economic landscape, the capacity of a business to access foreign markets is often a key determinant of its financial well-being and growth path. Investors now place great importance on grasping the extent of a company's dependence on international markets, as it sheds light on the firm's earnings stability, its skill in leveraging various economic cycles and its broad growth potential.
Presence in international markets can act as a hedge against domestic economic downturns and provide access to faster-growing economies. However, this diversification also brings complexities due to currency fluctuations, geopolitical risks and differing market dynamics.
In our recent assessment of XRAY's quarterly performance, we discovered notable trends in its overseas revenue sections, which are typically modeled and scrutinized by Wall Street analysts.
For the quarter, the company's total revenue amounted to $953 million, experiencing a decline of 2.6% year over year. Next, we'll explore the breakdown of XRAY's international revenue to understand the importance of its overseas business operations.
Trends in XRAY's Revenue from International Markets
Europe accounted for 39.5% of the company's total revenue during the quarter, translating to $376 million. Revenues from this region represented a surprise of -2.81%, with Wall Street analysts collectively expecting $386.89 million. When compared to the preceding quarter and the same quarter in the previous year, Europe contributed $397 million (39.2%) and $396 million (40.5%) to the total revenue, respectively.
Of the total revenue, $221 million came from Rest of World during the last fiscal quarter, accounting for 23.2%. This represented a surprise of -4.36% as analysts had expected the region to contribute $231.08 million to the total revenue. In comparison, the region contributed $247 million, or 24.4%, and $231 million, or 23.6%, to total revenue in the previous and year-ago quarters, respectively.
Revenue Projections for Overseas Markets
The current fiscal quarter's total revenue for Dentsply, as projected by Wall Street analysts, is expected to reach $1.02 billion, reflecting a decline of 0.4% from the same quarter last year. The breakdown of this revenue by foreign region is as follows: Europe is anticipated to contribute 39.3% or $402 million and Rest of World 25.1% or $256.98 million.
For the full year, the company is projected to achieve a total revenue of $3.99 billion, which signifies a rise of 0.6% from the last year. The share of this revenue from various regions is expected to be: Europe at 39% ($1.56 billion) and Rest of World at 24.7% ($985.88 million).
The Bottom Line
Dentsply's reliance on international markets for revenues offers both opportunities and risks. Hence, keeping an eye on its international revenue trends could significantly help forecast the company's prospects.
With the increasing intricacies of global interdependence and geopolitical strife, Wall Street analysts meticulously observe these patterns, especially for companies with an international footprint, to tweak their forecasts of earnings. Importantly, several additional factors, such as a company's domestic market status, also impact these earnings forecasts.
Emphasizing a company's shifting earnings prospects is a key aspect of our approach at Zacks, especially since research has proven its substantial influence on a stock's price in the short run. This correlation is positively aligned, meaning that improved earnings projections tend to boost the stock's price.
The Zacks Rank, our proprietary stock rating tool, comes with an externally validated impressive track record. It effectively utilizes shifts in earnings projections to act as a dependable barometer for forecasting short-term stock price trends.
Over the past month, the stock has seen a decline of 12.4% in its value, whereas the Zacks S&P 500 composite has posted a decrease of 1.6%. The Zacks Medical sector, Dentsply's industry group, has descended 1.4% over the identical span. In the past three months, there's been a decline of 13.7% in the company's stock price, against a rise of 3.8% in the S&P 500 index. The broader sector has declined by 0.9% during this interval.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Understanding Dentsply (XRAY) Reliance on International Revenue
Have you evaluated the performance of Dentsply International's (XRAY - Free Report) international operations for the quarter ending March 2024? Given the extensive global presence of this dental products manufacturer, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth.
In the modern, closely-knit global economic landscape, the capacity of a business to access foreign markets is often a key determinant of its financial well-being and growth path. Investors now place great importance on grasping the extent of a company's dependence on international markets, as it sheds light on the firm's earnings stability, its skill in leveraging various economic cycles and its broad growth potential.
Presence in international markets can act as a hedge against domestic economic downturns and provide access to faster-growing economies. However, this diversification also brings complexities due to currency fluctuations, geopolitical risks and differing market dynamics.
In our recent assessment of XRAY's quarterly performance, we discovered notable trends in its overseas revenue sections, which are typically modeled and scrutinized by Wall Street analysts.
For the quarter, the company's total revenue amounted to $953 million, experiencing a decline of 2.6% year over year. Next, we'll explore the breakdown of XRAY's international revenue to understand the importance of its overseas business operations.
Trends in XRAY's Revenue from International Markets
Europe accounted for 39.5% of the company's total revenue during the quarter, translating to $376 million. Revenues from this region represented a surprise of -2.81%, with Wall Street analysts collectively expecting $386.89 million. When compared to the preceding quarter and the same quarter in the previous year, Europe contributed $397 million (39.2%) and $396 million (40.5%) to the total revenue, respectively.
Of the total revenue, $221 million came from Rest of World during the last fiscal quarter, accounting for 23.2%. This represented a surprise of -4.36% as analysts had expected the region to contribute $231.08 million to the total revenue. In comparison, the region contributed $247 million, or 24.4%, and $231 million, or 23.6%, to total revenue in the previous and year-ago quarters, respectively.
Revenue Projections for Overseas Markets
The current fiscal quarter's total revenue for Dentsply, as projected by Wall Street analysts, is expected to reach $1.02 billion, reflecting a decline of 0.4% from the same quarter last year. The breakdown of this revenue by foreign region is as follows: Europe is anticipated to contribute 39.3% or $402 million and Rest of World 25.1% or $256.98 million.
For the full year, the company is projected to achieve a total revenue of $3.99 billion, which signifies a rise of 0.6% from the last year. The share of this revenue from various regions is expected to be: Europe at 39% ($1.56 billion) and Rest of World at 24.7% ($985.88 million).
The Bottom Line
Dentsply's reliance on international markets for revenues offers both opportunities and risks. Hence, keeping an eye on its international revenue trends could significantly help forecast the company's prospects.
With the increasing intricacies of global interdependence and geopolitical strife, Wall Street analysts meticulously observe these patterns, especially for companies with an international footprint, to tweak their forecasts of earnings. Importantly, several additional factors, such as a company's domestic market status, also impact these earnings forecasts.
Emphasizing a company's shifting earnings prospects is a key aspect of our approach at Zacks, especially since research has proven its substantial influence on a stock's price in the short run. This correlation is positively aligned, meaning that improved earnings projections tend to boost the stock's price.
The Zacks Rank, our proprietary stock rating tool, comes with an externally validated impressive track record. It effectively utilizes shifts in earnings projections to act as a dependable barometer for forecasting short-term stock price trends.
At the moment, Dentsply has a Zacks Rank #3 (Hold), signifying that its performance may align with the overall market trend in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Exploring Recent Trends in Dentsply's Stock Price
Over the past month, the stock has seen a decline of 12.4% in its value, whereas the Zacks S&P 500 composite has posted a decrease of 1.6%. The Zacks Medical sector, Dentsply's industry group, has descended 1.4% over the identical span. In the past three months, there's been a decline of 13.7% in the company's stock price, against a rise of 3.8% in the S&P 500 index. The broader sector has declined by 0.9% during this interval.